New York, New York

Sexual Health, HIV Prevention, and Primary Care in 2019

Registration Details

  • Early Registration: $75.00 (USD)
  • Early Registration ends: Thursday, August 29, 2019
  • Preregistration: $95.00 (USD)
  • Preregistration ends: Thursday, September 5, 2019
  • On-site Registration: $105.00 (USD)
  • On-site Registration ends: Thursday, September 12, 2019
  • Fellow/Student: $30.00 (USD)
  • Fellow/Student ends: Thursday, September 5, 2019
  • On-site Fellow/Student Registration: $30.00 (USD)
  • On-site Fellow/Student Registration ends: Thursday, September 12, 2019

Course Chairs

Roy M. Gulick, MD, MPH
Weill Cornell Medicine
Jeanne M. Marrazzo, MD, MPH, FACP, FIDSA
University of Alabama at Birmingham


September 12, 2019 - 8:30 AM


September 12, 2019 - 4:00 PM


TKP New York Conference Center - Empire Ballroom
109 W 39th Street
New York
New York
United States

This new course will focus on maintaining health for people with or at risk for HIV infection. This includes initiating and monitoring the use of prexposure prophylaxis (PrEP), sexual health including management and prevention of sexually transmitted infections (STIs), antiretroviral therapy during conception and pregnancy, and appropriate vaccines against preventable diseases. The course will address the notable increase in STIs that has paralleled increased uptake of PrEP. In convening this course, we will address the shift in primary responsibility for managing PrEP and STIs from HIV and infectious disease clinicians to primary care and internal medicine practitioners, as well as the need for widespread education around sexual health PrEP, and prevention throughout the medical community.

Assessment of Needs

The notable increase in sexually transmitted infections (STIs) that is paralleling the increase in uptake of preexposure prophylaxis (PrEP) as well as the shift in primary responsibility for managing PrEP and STIs from HIV and infectious disease clinicians to primary care and internal medicine practitioners is driving the need for a widespread educational effort. This course will address the best practices for maintaining the sexual health of those with or at risk for HIV infection. Information will be presented through a mix of didactic lectures and clinically relevant cases developed by an expert faculty of STI and HIV/AIDS clinicians and researchers.

Learning Objectives

After participating in the activity, learners will be better able to:

  • Describe the emerging epidemiology, clinical presentations and management of the most common sexually transmitted infections (STIs) in the era of biomedical prevention
  • Describe the fundamentals of staging, serology, and treatment of syphilis
  • Determine which patients might benefit from prevention intervention strategies, including the use of preexposure prophylaxis (PrEP), and initiate and monitor uninfected patients at risk for HIV infection
  • Apply newly available data to antiretroviral strategies for the management of established HIV infection in the context of conception and pregnancy
  • Apply newly available data to provide specific immunization guidance based on an individual’s immunologic status and assessed risk


Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.”


Who Should Attend

This course is designed for primary care clinicians and internal medicine practitioners as well as HIV specialists who are responsible for PrEP and STI management.

This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.

Representatives and employees of commercial companies (eg, pharmaceutical, diagnostic, medical products, advertising, insurance, investment, and communications firms) must contact the IAS–USA regarding registration procedures.

Cancellation Policy

Cancellation requests must be made 8 or more days before the date of an activity. All refunds will be processed minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ABIM MOC This activity is eligible for ABIM MOC Points; see the final activity announcement for details.

Nursing Credits

This activity is eligible for ANCC and pharmacotherapy credits; see the final CNE activity announcement for details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoThis activity is eligible for ACPE credit; see the final CPE activity announcement for details.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Food and beverages at IAS–USA events are purchased with registration fees, not with grant support money.

Requests for educational grants have been made to commercial companies with competing products. Information on grant support will be posted on the IAS–USA website as it becomes available.

Physician Payment Sunshine Act (“Sunshine Act” or “Open Payment”)

In 2014, the Physician Payment Sunshine Act (“Sunshine Act” or “Open Payments”), a provision of the Affordable Care Act, was developed. According to the Centers for Medicare and Medicaid Services (CMS): “Open Payments is a national disclosure program that promotes transparency by publishing the financial relationships between the medical industry and healthcare providers (physicians and hospitals) on a publicly accessible website developed by CMS.” Until recently, CME activities that receive commercial support have been exempt from reporting payments for goods such as hosted meals. Attendee registration fees are used for all food and beverage expenses provided by IAS–USA at the activity.